About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Combined Hormone Therapy Increases Risk of Breast Cancer

by Enozia Vakil on March 31, 2013 at 7:10 PM
 Combined Hormone Therapy Increases Risk of Breast Cancer

An increase in breast cancer incidence has been linked to the use of both estrogen and progestin as a therapy.

The study also found that prognosis is similar for combined hormone therapy's users and nonusers, suggesting that death from breast cancer may be higher for hormone therapy users as well.

Advertisement

In the Women's Health Initiative (WHI) randomized trial, estrogen plus progestin was associated with an increase in both breast cancer incidence and mortality.

In order to determine the differences between the WHI trial and other observational studies, Rowan T. Chlebowski, M.D., Ph.D., Los Angeles Biomedical Research Institute (LA BioMed) lead researcher and colleagues, looked at postmenopausal women, who had no prior hysterectomy with negative mammograms within two years and were either users or non-users of estrogen and progestin combined therapy.
Advertisement

They found that breast cancer incidence was higher in estrogen plus progestin users than incidence in nonusers.

Women who started hormone therapy closer to menopause had a higher breast cancer risk with a weakening influence as the time from menopause increased.

The researchers wrote that because survival after breast cancer diagnosis did not differ between estrogen plus progestin users and nonusers, the higher breast cancer incidence of those using estrogen plus progestin may lead to increased breast cancer mortality on a population basis.

The study has been published in the Journal of the National Cancer Institute.

Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Cancer News

Link Between Poor Oral Health and Head & Neck Cancer Survival Uncovered
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
Painless Lumps in the Body May Signal Lymphatic Cancer Risk
The presence of painless swelling in the lymph nodes could potentially indicate lymphatic cancer, say experts.
Non-clinical Genetic Testing May Lead to Needless Breast Surgery
Women tested at high risk for breast cancer using non-clinical genetic tests overlooking family history may decide to undergo unnecessary breast surgery.
Promising Drug Combination Offers Hope for Liver Cancer Patients
Atezolizumab-bevacizumab drug combination can yield positive outcomes in terms of extended survival and the elimination of liver cancer.
Most Esophageal Reflux Patients Face No Elevated Cancer Risk
Reflux disease manifests as acid regurgitation and heartburn and is a known risk factor for esophageal cancer.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Combined Hormone Therapy Increases Risk of Breast Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests